MINNEAPOLIS—DaVita Clinical Research (DCR) has hired four individuals to ignite the expansion of DCR at its latest clinical research facility in Denver, scheduled to open this month.
The new team members are Dr. Christopher Galloway, medical director; Chad Jaeger, senior director of Clinical Operations; Amy Denvir, director of Operations - Denver; and Michael Kreuter, director of Data Management.
With more than 12 years of medical practice, including six years in emergency and critical care, Galloway brings great industry experience in his new role as medical director for DCR. He served as an attending physician for Capitol Emergency Associates in Austin, Texas; Front Range Emergency Associates in Colorado Springs, Colo.; and the University of Tennessee in Knoxville.
Jaeger's involvement within the early clinical research industry spans the past 16 years in both clinical and commercial operations and includes former employers Harris Laboratories, MDS Pharma Services and Radiant Research. His last position prior to joining DCR was senior account executive for Covance's early clinical pharmacology units. A graduate of the University of Nebraska - Lincoln, Jaeger is a member of the American Society for Clinical Pharmacology and Therapeutics (ASCPT).
As the director of Operations, Denvir will use more than 20 years of early-phase CRO industry experience to launch the new Denver facility and ensure that Good Clinical Practice, the international quality standard for clinical trials, is maintained. Denvir formerly worked for Metroplex Clinical Research Center, Covance, Radiant Research and MDS Pharma Services in a variety of operational leadership roles.
